Nonhormonal Medical Treatment of Male Infertility

Endocrinology (Switzerland)

Volumn , Issue , 2017, Pages 1091-1113

  Calogero, Aldo E ^a   Condorelli, Rosita A ^a   La Vignera, Sandro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Male infertility; Nonhormonal treatment; Sperm parameters

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ANTIBIOTIC AGENT; ASCORBIC ACID; ASTAXANTHIN; AZITHROMYCIN; CARNITINE; CATALASE; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CYCLOOXYGENASE 2 INHIBITOR; DOXYCYCLINE; FOLLITROPIN; GLUTATHIONE; IBUPROFEN; INOSITOL; INTERLEUKIN 18; INTERLEUKIN 8; LEVOFLOXACIN; METRONIDAZOLE; MITOCHONDRIAL DNA; PREDNISONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SALICYLIC ACID DERIVATIVE; SCAVENGER; SOTALOL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; URIC ACID;

ANTIOXIDANT ASSAY; FIBRINOLYSIS; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; LIPID PEROXIDATION; MALE FERTILITY; PRIORITY JOURNAL; SEMEN ANALYSIS; SEMINAL PLASMA; SPERM QUALITY; SPERMATOGENESIS; SPERMATOGONIUM; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MATURATION; SPERMATOZOON MOTILITY; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; TRANSRECTAL ULTRASONOGRAPHY;

EID: 85164765666     PISSN: 25101927     EISSN: 25101935     Source Type: Book Series    
DOI: 10.1007/978-3-319-44441-3_37     Document Type: Chapter

References (124)

1. Abd-Allah AR, Aly HA, Moustafa AM, Abdel-Aziz AA, Hamada FM. Adverse testicular effects of some quinolone members in rats. Pharmacol Res. 2000;41(2):211.
2. Abel BJ, Carswell G, Elton R, Hargreave TB, Kyle K, Orr S, Rogers A, Baxby K, Yates A. Randomised trial of clomiphene citrate treatment and vitamin C for male infertility. Br J Urol. 1982;54:780.
3. Agarwal A, Said TM. Carnitines and male infertility. Reprod BioMed Online. 2004;8(4):376.
4. Agarwal A, Nallella KP, Allamaneni SS, Said TM. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod BioMed Online. 2004;8:616.
5. Agarwal A, Sharma RK, Desai NR, Prabakaran S, Tavares A, Sabanegh E. Role of oxidative stress in pathogenesis of varicocele and infertility. Urology. 2009;73:461.
6. Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health. 2014;32:1.
7. Aitken RJ. The Amoroso Lecture. The human spermatozoon–a cell in crisis? J Reprod Fertil. 1999;115:1.
8. Balercia G, Regoli F, Armeni T, Koverech A, Mantero F, Boscaro M. Placebo-controlled double-blind randomized trial on the use of L-carnitine, L-acetylcarnitine, or combined L-carnitine and L-acetylcarnitine in men with idiopathic asthenozoospermia. Fertil Steril. 2005;84(3):662.
9. Balercia G, Buldreghini E, Vignini A, Tiano L, Paggi F, Amoroso S, Ricciardo-Lamonica G, Boscaro M, Lenzi A, Littarru G. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009; 91(5):1785.
10. Banihani S, Agarwal A, Sharma R, Bayachou M. Cryoprotective effect of l-carnitine on motility, vitality and DNA oxidation of human spermatozoa. Andrologia. 2014;46(6):637.
11. Bornman MS, du Toit D, Otto B, Müller II, Hurter P, du Plessis DJ. Seminal carnitine, epididymal function and spermatozoal motility. S Afr Med J. 1989;75(1):20.
12. Bundrick W, Heron SP, Ray P, et al. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study. Urology. 2003;62:537.
13. Busetto GM, Koverech A, Messano M, Antonini G, De Berardinis E, Gentile V. Prospective open-label study on the efficacy and tolerability of a combination of nutritional supplements in primary infertile patients with idiopathic astenoteratozoospermia. Arch Ital Urol Androl. 2012;84:137.
14. Byun JS, Yoon TK, Rhee HW, Kim JH, Shin JS, Kim HS, Bak CW. Chronic pelvic pain syndrome and semen quality of Korean men in their fourth decade. J Androl. 2012;33(5):876.
15. Calogero AE, Gullo G, La Vignera S, Condorelli RA, Vaiarelli A. Myoinositol improves sperm parameters and serum reproductive hormones in patients with idiopathic infertility: a prospective double-blind randomized placebo-controlled study. Andrology. 2015;3(3):491.
16. Canale D, Scaricabarozzi I, Giorgi P, Turchi P, Ducci M, Menchini-Fabris GF. Use of a novel non-steroidal anti-inflammatory drug, nimesulide, in the treatment of abacterial pro-statovesiculitis. Andrologia. 1993;25(3):163.
17. Castellini C, Lattaioli P, Bernardini M, Dal Bosco A. Effect of dietary alpha-tocopheryl acetate and ascorbic acid on rabbit semen stored at 5 degrees C. Theriogenology. 2000;54(4):523.
18. Cheraghi E, Mehranjani MS, Shariatzadeh MA, Esfahani MH, Ebrahimi Z. N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reprod Fertil Dev. 2016; 28(6):723.
19. Ciftci H, Verit A, Savas M, Yeni E, Erel O. Effects of N-acetylcysteine on semen parameters and oxidative/antioxidant status. Urology. 2009;74(1):73.
20. Comhaire FH, Christophe AB, Zalata AA, Dhooge WS, Mahmoud AM, Depuydt CE. The effects of combined conventional treatment, oral antioxidants and essential fatty acids on sperm biology in subfertile men. Prostaglandins Leukot Essent Fat Acids. 2000;63(3):159.
21. Comhaire FH, El Garem Y, Mahmoud A, Eertmans F, Schoonjans F. Combined conventional/ antioxidant “Astaxanthin” treatment for male infertility: a double blind, randomized trial. Asian J Androl. 2005;7(3):257.
22. Condorelli RA, La Vignera S, Di Bari F, Unfer V, Calogero AE. Effects of myoinositol on sperm mitochondrial function in-vitro. Eur Rev Med Pharmacol Sci. 2011;15(2):129.
23. Condorelli RA, La Vignera S, Bellanca S, Vicari E, Calogero AE. Myoinositol: does it improve sperm mitochondrial function and sperm motility? Urology. 2012;79(6):1290.
24. Cooper TG, Weidner W, Nieschlag E. The influence of inflammation of the human male genital tract on secretion of the seminal markers alpha-glucosidase, glycerophosphocholine, carnitine, fructose and citric acid. Int J Androl. 1990;13(5):329.
25. Costa M, Canale D, Filicori M, D’lddio S, Lenzi A. L-carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility. Andrologia. 1994;26(3):155.
26. Cui D, Han G, Shang Y, Liu C, Xia L, Li L, Yi S. Antisperm antibodies in infertile men and their effect on semen parameters: a systematic review and meta-analysis. Clin Chim Acta. 2015;444:29.
27. Cyrus A, Kabir A, Goodarzi D, Moghimi M. The effect of adjuvant vitamin C after varicocele surgery on sperm quality and quantity in infertile men: a double blind placebo controlled clinical trial. Int Braz J Urol. 2015;41:230.
28. Dawson EB, Harris WA, Teter MC, Powell LC. Effect of ascorbic acid supplementation on the sperm quality of smokers. Fertil Steril. 1992;58(5):1034.
29. De Celis R, Pedron-nuevo N, Feria-velasco A. Toxicology of male reproduction in animals and humans. Arch Androl. 1996;37:201.
30. De Rosa M, Boggia B, Amalfi B, Zarrilli S, Vita A, Colao A, Lombardi G. Correlation between seminal carnitine and functional spermatozoal characteristics in men with semen dysfunction of various origins. Drugs R D. 2005;6(1):1.
31. Doba T, Burton GW, Ingold KU. Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. Biochim Biophys Acta. 1985;835(2):298.
32. Duffy DM, VandeVoort CA. Maturation and fertilization of nonhuman primate oocytes are compromised by oral administration of a cyclooxygenase-2 inhibitor. Fertil Steril. 2011; 95(4):1256.
33. El-Harouny MA, Zalata AA, Naser ME, Abo El-Atta HM, El-Shawaf IM, Mostafa T. Long-term ofloxacin testicular toxicity: an experimental study. Andrologia. 2010;42(2):92.
34. ElSheikh MG, Hosny MB, Elshenoufy A, Elghamrawi H, Fayad A, Abdelrahman S. Combination of vitamin E and clomiphene citrate in treating patients with idiopathic oligoasthenozoospermia: a prospective randomized trial. Andrology. 2015;3:864–7.
35. Eskenazi B, Kidd SA, Marks AR, Sloter E, Block G, Wyrobek AJ. Antioxidant intake is associated with semen quality in healthy men. Hum Reprod. 2005;20(4):1006.
36. Farombi EO, Ugwuezunmba MC, Ezenwadu TT, Oyeyemi MO, Ekor M. Tetracycline-induced reproductive toxicity in male rats: effects of vitamin C and N-acetylcysteine. Exp Toxicol Pathol. 2008;60(1):77.
37. Fisher HM, Aitken RJ. Comparative analysis of the ability of precursor germ cells and epididymal spermatozoa to generate reactive oxygen metabolites. J Exp Zool. 1997;277:390.
38. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl AcadSci USA. 1989;86(16):6377.
39. Fujii J, Iuchi Y, Matsuki S, Ishii T. Cooperative function of antioxidant and redox systems against oxidative stress in male reproductive tissues. Asian J Androl. 2003;5(3):231.
40. Gambera L, Serafini F, Morgante G, Focarelli R, De Leo V, Piomboni P. Sperm quality and pregnancy rate after COX-2 inhibitor therapy of infertile males with abacterial leukocytospermia. Hum Reprod. 2007;22(4):1047.
41. Geva E, Bartoov B, Zabludovsky N, Lessing JB, Lerner-Geva L, Amit A. The effect of antioxidant treatment on human spermatozoa and fertilization rate in an in vitro fertilization program. Fertil Steril. 1996;66(3):430.
42. Ghanem H, Shaeer O, El-Segini A. Combination clomiphene citrate and antioxidant therapy for idiopathic male infertility: a randomized controlled trial. Fertil Steril. 2010;93:2232.
43. Giovenco P, Amodei M, Barbieri C, Fasani R, Carosi M, Dondero F. Effects of kallikrein on the male reproductive system and its use in the treatment of idiopathic oligozoospermia with impaired motility. Andrologia. 1987;19:238.
44. Gomez E, Buckingham DW, Brindle J, Lanzafame F, Irvine DS, Aitken RJ. Development of an image analysis system to monitor the retention of residual cytoplasm by human spermatozoa: correlation with biochemical markers of the cytoplasmic space, oxidative stress, and sperm function. J Androl. 1996;17:276.
45. Grabe M, Bjerklund-Johansen TE, Botto H et al. Guidelines on urological infections. Eur Assoc Urol; 2013. Available at: http://uroweb.org/wp-content/uploads/18_Urological-infections_LR. pdf.
46. Greco E, Iacobelli M, Rienzi L, Ubaldi F, Ferrero S, Tesarik J. Reduction of the incidence of sperm DNA fragmentation by oral antioxidant treatment. J Androl. 2005a;26(3):349.
47. Greco E, Romano S, Iacobelli M, Ferrero S, Baroni E, Minasi MG, Ubaldi F, Rienzi L, Tesarik J. ICSI in cases of sperm DNA damage: beneficial effect of oral antioxidant treatment. Hum Reprod. 2005b;20(9):2590.
48. Gulino FA, Leonardi E, Marilli I, Musmeci G, Vitale SG, Leanza V, Palumbo MA. Effect of treatment with myo-inositol on semen parameters of patients undergoing an IVF cycle: in vivo study. Gynecol Endocrinol. 2016;32(1):65.
49. Gvozdjáková A, Kucharská J, Dubravicky J, Mojto V, Singh RB. Coenzyme Q10, α-tocopherol, and oxidative stress could be important metabolic biomarkers of male infertility. Dis Markers. 2015; 827941.
50. Hargreave TB, Kyle KF, Baxby K, Rogers AC, Scott R, Tolley DA, Abel BJ, Orr PS, Elton RA. Randomised trial of mesterolone versus vitamin C for male infertility. Scottish Infertility Group. Br J Urol. 1984;56:740–4.
51. Jacob RA, Pianalto FS, Agee RE. Cellular ascorbate depletion in healthy men. J Nutr. 1992; 122(5):1111.
52. Jung JH, Seo JT. Empirical medical therapy in idiopathic male infertility: Promise or panacea? Clin Exp Reprod Med. 2014;41(3):108.
53. Kennedy JH, Korn N, Thurston RJ. Prostaglandin levels in seminal plasma and sperm extracts of the domestic turkey, and the effects of cyclooxygenase inhibitors on sperm mobility. Reprod Biol Endocrinol. 2003;1:74.
54. Kessopoulou E, Powers HJ, Sharma KK, Pearson MJ, Russel JM, CookeI D, Barrat CL. A double–blind randomized placebo cross–over controlled trial using the antioxidant vitamin E to treat reactive oxygen species associated male infertility. Fertil Steril. 1995;64(4):825.
55. La Vignera S, Condorelli RA, Vicari E, Tumino D, Morgia G, Favilla V, Cimino S, Calogero AE. Markers of semen inflammation: supplementary semen analysis? J Reprod Immunol. 2013;100(1):2.
56. La Vignera S, Condorelli RA, Vicari E, Salmeri M, Morgia G, Favilla V, Cimino S, Calogero AE. Microbiological investigation in male infertility: a practical overview. J Med Microbiol. 2014;63:1.
57. La Vignera S, Vicari E, Condorelli RA, Franchina C, Scalia G, Morgia G, Perino A, Schillaci R, Calogero AE. Prevalence of human papilloma virus infection in patients with male accessory gland infection. Reprod BioMed Online. 2015;30(4):385.
58. Lackner JE, Herwig R, Schmidbauer J, Schatzl G, Kratzik C, Marberger M. Correlation of leukocytospermia with clinical infection and the positive effect of antiinflammatory treatment on semen quality. Fertil Steril. 2006;86(3):601.
59. Lafuente R, Gonzàlez-Comadràn M, Solà I, Lòpez G, Brassesco M, Carreras R, Checa MA. Coenzyme Q10 and male infertility: a meta-analysis. J Assist Reprod Genet. 2013;30:1147.
60. Lahdetie J. Occupation-and exposure-related studies on human sperm. J Occup Environ Med. 1995;37:922.
61. Lancaster JW, Mahoney MV, Mandal S, Lawrence KR. Update on Treatment Options for Gono-coccal Infections. Pharmacotherapy. 2015;35(9):856.
62. Lanzafame FM, La Vignera S, Vicari E, Calogero AE. Oxidative stress and medical antioxidant treatment in male infertility. Reprod BioMed Online. 2009;19(5):638.
63. Lenzi A, Lombardo F, Gandini L, Dondero F. Metabolism and action of L-carnitine: its possible role in sperm tail function. Arch Ital Urol Nefrol Androl. 1992;64(2):187.
64. Lenzi A, Culasso F, Gandini L, Lombardo F, Dondero F. Placebo-controlled, double-blind, crossover trial of glutathione therapy in male infertility. Hum Reprod. 1993;8(10):1657.
65. Lenzi A, Picardo M, Gandini L, Lombardzo F, Terminali O, Passi S, Dondero F. Glutathione treatment of dyspermia: effect on the lipoperoxidation process. Hum Reprod. 1994;9(11):2044.
66. Lenzi A, Lombardo F, Sgrò P, Salacone P, Caponecchia L, Dondero F, Gandini L. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial. Fertil Steril. 2003;79(2):292.
67. Lenzi A, Sgrò P, Salacone P, Paoli D, Gilio B, Lombardo F, Santulli M, Agarwal A, Gandini L. A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. Fertil Steril. 2004;81(6):1578.
68. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 1996;93(8):3704.
69. Li Z, Chen GW, Shang XJ, Bai WJ, Han YF, Chen B, Teng XM, Meng FH, Zhang B, Chen DN, Liu JH, Zheng XM, Cao XR, Liu Y, Zhu XB, Wang YX. A controlled randomized trial of the use of combinated L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia. Zhonghua Nan KeXue. 2005;11:761–4.
70. Magri V, Marras E, Skerk V, et al. Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. Andrologia. 2010;42:366.
71. Magri V, Montanari E, Skerk V, et al. Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl. 2011;13:819.
72. Makker K, Agarwal A, Sharma R. Oxidative stress & male infertility. Indian J Med Res. 2009; 129(4):357.
73. Mancini A, Conte G, Milardi D, de Marinis L, Littarru GP. Relationship between sperm cell ubiquinone and seminal parameters in subjects with and without varicocele. Andrologia. 1998;30(1):1.
74. Manson JM, Zolna LE, Kang YJ, Johnson CM. Effects of cefonicid and other cephalosporin antibiotics on male sexual development in rats. Antimicrob Agents Chemother. 1987;31(7):991.
75. Milardi D, Luca G, Grande G, Ghezzi M, Caretta N, Brusco G, De Filpo G, Marana R, Pontecorvi A, Calafiore R, Foresta C, Garolla A. Prednisone treatment in infertile patients with oligozoospermia and accessory gland inflammatory alterations Andrology. 2017;5(2):268.
76. Mishra M, Acharya UR. Protective action of vitamins on the spermatogenesis in lead-treated Swiss mice. J Trace Elem Med Biol. 2004;18(2):173.
77. Moilanen J, Hovatta O. Excretion of alpha-tocopherol into human seminal plasma after oral administration. Andrologia. 1995;27(3):133.
78. Moilanen J, Hovatta O, Lindroth L. Vitamin E levels in seminal plasma can be elevated by oral administration of vitamin E in infertile men. Int J Androl. 1993;16(2):165.
79. Moncada ML, Vicari E, Cimino C, Calogero AE, Mongioì A, D'Agata R. Effect of acetylcarnitine treatment in oligoasthenospermicpatients. Acta Eur Fertil. 1992;23(5):221.
80. Mortazavi M, Salehi I, Alizadeh Z, Vahabian M, Roushandeh AM. Protective effects of antioxidants on sperm parameters and seminiferous tubules epithelium in high fat-fed rats. J Reprod Infertil. 2014;15(1):22.
81. Nadjarzadeh A, Sadeghi MR, Amirjannati N, Vafa MR, Motevalian SA, Ohari MR, Akhondi MA, Yavari P, Shidfar F. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenozoospermia: a randomized double-blind, placebo cotrolled trial. J Endocrinol Investig. 2011;34:224–8.
82. Nadjarzadeh A, Shidfar F, Amirjannati N, Vafa MR, Motevalian SA, Gohari MR, NazeriKakhki SA, Akhondi MM, Sadeghi MR. Effect of Coenzyme Q10 supplementation on antioxidant enzymes activity and oxidative stress of seminal plasma: a double-blind randomized clinical trial. Andrologia. 2014;46:177–83.
83. Naz RK. Modalities for treatment of antisperm antibody mediated infertility: novel perspectives. Am J Reprod Immunol. 2004;51(5):390.
84. Ng CM, Blackman MR, Wang C, Swerdloff RS. The role of carnitine in the male reproductive system. Ann N Y Acad Sci. 2004;1033:177.
85. Oh MM, Chae JY, Kim JW, Kim JW, Yoon CY, Park MG, Moon du G. Positive culture for extended-spectrum β-lactamase during acute prostatitis after prostate biopsy is a risk factor for progression to chronic prostatitis. Urology. 2013;81(6):1209.
86. Opuwari CS, Henkel RR. An update on oxidative damage to spermatozoa and oocytes. Biomed Res Int. 2016;2016(9540142).
87. Perletti G, Marras E, Wagenlehner FM, Magri V. Antimicrobial therapy for chronic bacterial prostatitis Cochrane Database Syst Rev. 2013;(8) CD009071.
88. Porat-Soldin O, Soldin SJ. Preliminary studies on the in vitro and in vivo effect of salicylate on sperm motility. Ther Drug Monit. 1992;14(5):366.
89. Rees J, Abrahams M, Doble A, Cooper A. Prostatitis Expert Reference Group (PERG). Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int. 2015;116(4):509–25.
90. Rolf C, Cooper TG, Yeung CH, Nieschlag E. Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod. 1999;14:1028–33.
91. Roodbari F, Abedi N, Talebi AR. Early and late effects of Ibuprofen on mouse sperm parameters, chromatin condensation, and DNA integrity in mice. Iran J Reprod Med. 2015;13(11):703.
92. Rubino P, Palini S, Chigioni S, Carlomagno G, Quagliarello A, De Stefani S, Baglioni A, Bulletti C. Improving fertilization rate in ICSI cycles by adding myoinositol to the semen preparation procedures: a prospective, bicentric, randomized trial on sibling oocytes. J Assist Reprod Genet. 2015;32:387–94.
93. Safarinejad MR. Efficacy of coenzyme Q10 on semen parameters, sperm function and reproductive hormones in infertile men. J Urol. 2009;182(1):237.
94. Safarinejad MR. The effect of coenzyme Q10 supplementation on partner pregnancy rate in infertile men with idiopathic oligoasthenoteratozoospermia: an open-label prospective study. Int Urol Nephrol. 2012;44(3):689.
95. Safarinejad MR, Safarinejad S. Efficacy of selenium and/or N-acetyl-cysteine for improving semen parameters in infertile men: a double-blind, placebo controlled, randomized study. J Urol. 2009;181(2):741–51.
96. Sharma RK, Kalla NR. Spermatozoal abnormalities and male infertility in the rat following sulfasalazine treatment. Int J Fertil Menopausal Stud. 1994;39(6):347.
97. Shin T, Kobori Y, Suzuki K, Iwahata T, Yagi H, Soh S, Arai G, Okada H. Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility. Syst Biol Reprod Med. 2014;60(6):373.
98. Showell MG, Mackenzie-Proctor R, Brown J, Yazdani A, Stankiewicz MT, Hart RJ. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2014; (12). CD007411.
99. da Silva RF, dos Santos Borges C, Villela P, Villela S, Missassi G, Kiguti LRA, Pupo AS, Barbosa FJ, Anselmo-Franci JA, De Grava Kempinas W. The Coadministration of N-acetylcysteine ameliorates the effects of arsenic trioxide on the male mouse genital system. Oxid Med Cell Longev. 2016; 4257498.
100. Singh AC, Kumar M, Jha AM. Genotoxicity of lomefloxacin–an antibacterial drug in somatic and germ cells of Swiss albino mice in vivo. Mutat Res. 2003;535(1):35.
101. Singh RP, Sastry KV, Dubey PK, Agrawal R, Singh R, Pandey NK, Mohan J. Norfloxacin drug induces reproductive toxicity and alters androgen receptor gene expression in testes and cloacal gland of male Japanese quail (Coturnix japonica). Environ Toxicol Chem. 2013;32(9):2134.
102. Skerk V, Scheonwald S, Krhen I, et al. Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis. J Chemother. 2002;14:384.
103. Skerk V, Schönwald S, Krhen I, Banaszak A, Begovac J, Strugar J, Strapac Z, Vrsalovic R, Vukovic J, Tomas M. Comparative analysis of azithromycin and ciprofloxacin in the treatment of chronic prostatitis caused by Chlamydia trachomatis. Int J Antimicrob Agents. 2003;21:457.
104. Skerk V, Krhen I, Lisi M, Krhen I, Lisić M, Begovac J, Roglić S, Skerk V, Sternak SL, Banaszak A, Strugar-Suica J, Vuković J. Comparative randomized pilot study of azithromycin and doxycy-cline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. Int J Antimicrob Agents. 2004;24:188.
105. Slowikowska-Hilczer J. Xenobiotics with estrogen or antiandrogen action – disruptors of the male reproductive system. CEJM. 2006;3:205.
106. Song GJ, Norkus EP, Lewis V. Relationship between seminal ascorbic acid and sperm DNA integrity in infertile men. Int J Androl. 2006;29(6):569.
107. Suleiman SA, Ali ME, Zaki ZM, el-Malik EM, Nasr MA. Lipid peroxidation and human sperm motility: protective role of vitamin E. J Androl. 1996;17(5):530.
108. Thérond P, Auger J, Legrand A, Jouannet P. Alpha-Tocopherol in human spermatozoa and seminal plasma: relationships with motility, antioxidant enzymes and leukocytes. Mol Hum Reprod. 1996;2(10):739.
109. Thiele JJ, Friesleben HJ, Fuchs J, Ochsendorf FR. Ascorbic acid and urate in human seminal plasma: determination and interrelationships with chemiluminescence in washed semen. Hum Reprod. 1995;10(1):110.
110. Thonneau P, Bujan L, Multigner L, Mieusset R. Occupational heat exposure and male fertility: a review. Hum Reprod. 1998;13:2122.
111. Tripodi L, Tripodi A, Mammí C, Pullé C, Cremonesi F. Pharmacological action and therapeutic effects of glutathione on hypokinetic spermatozoa for enzymatic-dependent pathologies and correlated genetic aspects. Clin Exp Obstet Gynecol. 2003;30(2–3):130.
112. Ugochukwu AP, Ebere OO, Okwuoma A. Effects of nimesulide on testicular functions in prepubertal albino rats. J Basic Clin Physiol Pharmacol. 2011;22(4):137.
113. Vargas A, Bustos-Obregón E, Hartley R. Effects of hypoxia on epididymal sperm parameters and protective role of ibuprofen and melatonin. Biol Res. 2011;44(2):161.
114. Vicari E, Calogero AE. Effects of treatment with carnitines in infertile patients with prostato-vesiculo-epididymitis. Hum Reprod. 2001;16(11):2338.
115. Vicari E, Rubino C, De Palma A, Longo G, Lauretta M, Consoli S, Arancio A. Antioxidant therapeutic efficiency after the use of carnitine in infertile patients with bacterial or non-bacterial prostato-vesiculo-epididymitis. Arch Ital Urol Androl. 2001;73(1):15.
116. Vicari E, La Vignera S, Calogero AE. Antioxidant treatment with carnitines is effective in infertile patients with prostatovesiculoepididymitis and elevated seminal leukocyte concentrations after treatment with nonsteroidal anti-inflammatory compounds. Fertil Steril. 2002;78(6):1203.
117. Vitali G, Parente R, Melotti C. Carnitine supplementation in human idiopathic asthenospermia: clinical results. Drugs Exp Clin Res. 1995;21(4):157.
118. Walczak-Jedrzejowska R, Wolski JK, Slowikowska-Hilczer J. The role of oxidative stress and antioxidants in male fertility. Cent European J Urol. 2013;66(1):60.
119. Wayner DD, Burton GW, Ingold KU. The antioxidant efficiency of vitamin C is concentration-dependent. Biochim Biophys Acta. 1986;884(1):119.
120. Wen Y, Cooke T, Feely J. The effect of pharmacological supplementation with vitamin C on low-density lipoprotein oxidation. Br J Clin Pharmacol. 1997;44(1):94.
121. Wolfson JS, Hooper DC. Pharmacokinetics of quinolones: newer aspects. Eur J Clin Microbiol Infect Dis. 1991;10(4):267.
122. World Health Organization. WHO Laboratory Manual for the Examination and Processing of Human Semen. 5th ed. Geneva: World Health Organization; 2010.
123. Yanushpolsky EH, Politch JA, Hill JA, Anderson DJ. Is leukocytospermia clinically relevant? Fertil Steril. 1996;66(5):822.
124. Zhang ZC, Jin FS, Liu DM, Shen ZJ, Sun YH, Guo YL. Safety and efficacy of levofloxacin versus ciprofloxacin for the treatment of chronic bacterial prostatitis in Chinese patients. Asian J Androl. 2012;14:870.